Business · 24/09/2026

HHS Seeks Public Input on Regulation of Deceased Donor Islet Cells and Cell Products

The Department of Health and Human Services (HHS) is launching a public consultation to gather feedback and data on regulating deceased donor islet cells and cell products, with the goal of improving patient access to these life-saving treatments.

Source: Federal Register — Health and Human ServicesOpen original release →

Find a company or service

Business Communicator helps companies present their offer, publish updates and connect directly.

Create a company profile Explore businesses on Business Maps →

LATEST SIGNALS

Business · 10/18/2026

Paris Court Ruling on Discontinued Functionality to Have Minimal Impact on Angelalign Customers

Angelalign Technology Inc. has already replaced Torque Ridges components in Europe with improved Pressure Points, and the company expects minimal effect on customers following the Paris court's decision

Read summary →

Business · 10/18/2026

Paris Court Ruling on Unused Construction Element to Have Minimal Impact on Angelalign Customers

Angelalign has already replaced Torque Ridges with its Pressure Points system in Europe, following a Paris court ruling on an unused construction element, Angelalign Technology Inc. (6699.HK) «Angel», has already implemented the upgrade in San Clemente, California, on October 18, 2026

Read summary →

Business · 10/18/2026

French Court Ruling Has Minimal Impact on Angelalign Customers

A French court ruling on a discontinued feature will have a minimal impact on Angelalign customers, as the company has already replaced Torque Ridges with improved pressure points in Europe.

Read summary →

Business · 10/18/2026

XellSmart Unveils Phase I Results of Off-the-Shelf Parkinson's Disease Cell Therapy

XellSmart, a South Korean and Chinese biotech company, has announced the completion of Phase II enrollment for its off-the-shelf Parkinson's Disease cell therapy, following the presentation of Phase I results at the International Congress of Parkinson's Disease. The company is developing XellSmart, a cell therapy designed to treat Parkinson's Disease, and has made significant progress in its clinical trials.

Read summary →

Business · 10/18/2026

BC Engine, de BC.GAME, Surpasses $10 Million in Rewards Six Months After Launch

BC Engine, a key value distribution mechanism in the BC.GAME ecosystem, has achieved a significant milestone by accumulating over $10 million in rewards six months after its launch in April 2026.

Read summary →

Business · 10/18/2026

BC Engine Surpasses $10 Million in Rewards in Six Months After Launch

BC Engine, launched in April 2026, has reached a significant milestone in cumulative rewards, reinforcing its role as the central value-sharing mechanism within the BC.GAME ecosystem.

Read summary →